← FDA Drug Approvals (Drugs@FDA)

BOSULIF

NDA · New Drug Application · Sponsor: PF PRISM CV · Approved 2023-09-26

Drug application

FDA Application #

NDA217729

Application type

New Drug Application

Brand name

BOSULIF

Generic name

BOSUTINIB

Active ingredients

BOSUTINIB MONOHYDRATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

PF PRISM CV

Manufacturer

Pfizer Laboratories Div Pfizer Inc

First approval

2023-09-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown